Japan represents one of the world’s largest single-country pharma markets, but as of 2020, 72% of drugs approved for use in Europe and the United States were not approved in Japan.
Read this free article now to:
- Discover the scope of opportunities available in the Japanese market.
- Uncover the truth behind several misapprehensions about drug development in Japan.
- Examine the benefits of conducting clinical research in Japan.
- Explore how effective collaborations between CROs and biotechs can ease the entry for drugs into Japan.
Download the article: Japan’s Strengths As A Clinical Study Location And Why Selecting The Right Partner Is Crucial